C

Cellective BioTherapy, Inc.

2 employees

Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Information Technology
Medical Device
Medical
Health Care

Date founded

2015

Funding rounds raised

Total raised

$2.5M

from 2 investors over 2 rounds

C

Cellective BioTherapy, Inc. raised $2.5M on June 12, 2015

Investors: Eshelman Ventures, LLC

C

Cellective BioTherapy, Inc. raised undisclosed on January 1, 2004

Investors: Sofinnova Ventures, Russia technology fund

FAQ